Infectious Disease Book

http://www.fpnotebook.com/

Acyclovir

Aka: Acyclovir, Zovirax
  1. Indications
    1. Primary or Recurrent Herpes Simplex Virus Infection
      1. Oral Herpes (Herpes Labialis)
      2. Genital Herpes
    2. HSV Encephalitis
    3. HSV Keratitis
    4. Herpes Neonatorum
    5. Herpes Zoster
    6. Genital Herpes
    7. Varicella Zoster Virus (Chicken Pox)
    8. Herpes Zoster Ophthalmicus
    9. Herpes Labialis
  2. Pharmacokinetics
    1. Metabolized by Kidney
      1. Decrease interval in renal Impairment to q12-24h
    2. Dialysis: 50-100% dialyzable
  3. Pregnancy and Lactation
    1. FDA Pregnancy Class C
    2. Safety unclear in Breast Feeding
  4. How Supplied
    1. Tablets: 200, 400, 800 mg
    2. Suspension: 200 mg/5 ml
  5. Dosing: Systemic Acyclovir
    1. General
      1. Base Weight calculations on Lean Body Mass
    2. HSV Encephalitis or Herpes Neonatorum
      1. Child: 30 mg/kg/day (1500 mg/m2/day) divided q8h IV
    3. Primary Herpetic Gingivostomatitis
      1. Adult: 200 mg PO q4 hours while awake (5x/day)
      2. Ped: 15 mg/kg/d (750 mg/m2/d) divide q8h IV x5-10 day
    4. Initial Genital HSV
      1. Adult: 200 mg PO 5 times per day for 10 days
    5. Episodic Genital HSV
      1. Adult: 200 mg PO 5 times per day for 5 days
    6. Prophylaxis of Genital HSV
      1. Adult: 400 mg PO bid for up to 12 months
    7. Herpes Zoster (Shingles) or Herpes Ophthalmicus
      1. Adult Oral: 800 mg PO 5 times/day for 7-10 days
      2. Adult IV: 10-12 mg/kg/dose q8 hours for 7-14 days
    8. Varicella Zoster Virus (Chicken Pox)
      1. Child
        1. Dose: 10-20 mg/kg/dose to 800 mg PO qid for 5 days
      2. Adult
        1. Dose: 600-800 mg/dose PO q4h while awake (5x/day)
        2. Dose: 1000 mg/dose PO q6h for 5 days
      3. Intravenous
        1. Dose: 30 mg/kg/day (1500 mg/m2/day) divided q8h IV
  6. Dosing: Topical Acyclovir
    1. Initial genital HSV
      1. Apply to affected area 6 times per day for 7 days
  7. Adverse Effects
    1. Headache
    2. Gastrointestinal Upset
    3. Impaired Renal Function
    4. CNS depression
      1. Lethargy
      2. Confusion
      3. Coma
    5. Tremors
    6. Agitation
  8. Drug Interactions (prolong Acyclovir half life)
    1. Probenecid
    2. Zidovudine
  9. Precautions
    1. Overdose may result in Renal Failure
    2. Maintain adequate urine to flush renal tubules
  10. Efficacy: Herpes Labialis (Oral Herpes)
    1. Only effective if used at outset of symptoms
    2. Shortens Vesicle life and decreases shedding
    3. Prevents recurrence in immunocompromised
    4. Reduction in episodes: 53%
    5. Quicker healing: 4 days instead of 8 for Placebo
    6. Reduction in number of Fever Blisters: 71%

Acyclovir (C0001367)

Definition (CHV) a drug used to treat initial genital herpes infections
Definition (NCI) A substance used to prevent or treat cytomegalovirus and herpes simplex infections that may occur when the body is immunosuppressed. It belongs to the family of drugs called antivirals.
Definition (MSH) A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.
Definition (CSP) 9-(2-hydroxyethoxymethyl) guanine; acts against herpesviruses by inhibiting the viral DNA polymerase.
Definition (NCI) A synthetic analog of the purine nucleoside, guanosine, with potent antiviral activity against herpes simplex viruses type 1 and 2, varicella-zoster virus and other viruses. After conversion in vivo to the active metabolite acyclovir triphosphate, acyclovir competitively inhibits viral DNA polymerase, incorporates into and terminates the growing viral DNA chain, and inactivates viral DNA polymerase. The greater antiviral activity of acyclovir against HSV compared to VZV is due to its more efficient phosphorylation by the thymidine kinase of HSV. (NCI04)
Definition (PDQ) A synthetic analog of the purine nucleoside, guanosine, with potent antiviral activity against herpes simplex viruses type 1 and 2, varicella-zoster virus and other viruses. After conversion in vivo to the active metabolite acyclovir triphosphate, acyclovir competitively inhibits viral DNA polymerase, incorporates into and terminates the growing viral DNA chain, and inactivates viral DNA polymerase. The greater antiviral activity of acyclovir against HSV compared to VZV is due to its more efficient phosphorylation by the thymidine kinase of HSV. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39134&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39134&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C205" NCI Thesaurus)
Concepts Nucleic Acid, Nucleoside, or Nucleotide (T114) , Pharmacologic Substance (T121)
MSH D000212
SnomedCT 330282004, 333010007, 425884003, 324721009, 391710009, 372729009, 41193000
English Aciclovir, Acycloguanosine, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-, Aciclovir [eyes], Aciclovir [skin], Aciclovir [systemic], Acyclovir [eyes], Acyclovir [skin], Acyclovir [systemic], 9-((2-Hydroxyethoxy)methyl)guanine, 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one, 9-[(2-Hydroxyethoxy)-methyl]guanine, 9-[(2-Hydroxyethoxy)methyl]guanine, acyclovir, ACV, Aciclovir [eyes] (product), Ophthalmic form aciclovir, Aciclovir [systemic] (product), Aciclovir [skin] (product), Ophthalmic form acyclovir (product), Ophthalmic form acyclovir, acyclovir (medication), Aciclovir - chemical (substance), ACYCLOVIR, Acyclovir [Chemical/Ingredient], Acyclovir (product), Acyclovir (substance), acycloguanosine, Acyclovir, Aciclovir - chemical, Aciclovir [eyes] (substance), Aciclovir [skin] (substance), Aciclovir [systemic] (substance)
Swedish Aciklovir
Czech acykloguanosin, acyklovir
Spanish aciclovir, forma oftálmica, aciclovir [uso sistémico], Aciclovir - chemical, aciclovir [uso oftálmico] (producto), aciclovir, forma oftálmica (producto), aciclovir (uso dermatológico), aciclovir [uso sistémico] (producto), aciclovir (uso dermatológico) (producto), aciclovir [uso oftálmico], acicloguanosina, aciclovir (piel) (producto), aciclovir (piel), aciclovir (producto), aciclovir (sustancia), aciclovir [oftálmico] (producto), aciclovir [oftálmico], aciclovir [sistémico] (producto), aciclovir [sistémico], aciclovir, Acicloguanosina, Aciclovir
Finnish Asykloviiri
Russian ATSIKLOGUANOZIN, ATSIKLOVIR, АЦИКЛОВИР, АЦИКЛОГУАНОЗИН
Japanese アシクロビル, アシクログアノシン
Polish Acyklowir, Acyklognanozyna
French Aciclovir, Acycloguanosine, 9-((2-Hydroxyethoxy)methyl)guanine, Acyclovir
German Aciclovir, Acycloguanosin, Acyclovir, Azyklovir
Italian Acyclovir
Portuguese Acicloguanosina, Aciclovir
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Zovirax (C0592290)

Concepts Nucleic Acid, Nucleoside, or Nucleotide (T114) , Pharmacologic Substance (T121)
MSH D000212
English zovirax, Glaxo Wellcome Brand of Aciclovir Sodium Salt, Glaxo Wellcome Brand of Aciclovir, Parke Davis Brand of Aciclovir, Warner Wellcome Brand of Aciclovir, Wellcome Brand of Aciclovir Sodium Salt, Wellcome Brand of Aciclovir, Zovirax for Injection, Aciclovir Wellcome Brand, Zovirax
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree